I have developed some model scenarios that show examples of what might be behind expert advice on the caution required with new SARS-Cov-2 variants. The scenarios indicate the importance of the UK vaccine programme, as we face variants with potentially different characteristics of transmission, severity of infection and responsiveness to vaccines. Understanding those variant characteristics is vital for projections.
Tag Archives: Vaccine
Why the UK Government is worried about new variants
I have developed some model scenarios that show examples of what might be behind expert advice on the caution required with new SARS-Cov-2 variants. The scenarios indicate the importance of the UK vaccine programme, as we face variants with potentially different characteristics of transmission, severity of infection and responsiveness to vaccines.
NPIs, variants and vaccine models
This paper reports some parametric Coronavirus model runs I have made that compare, in particular, how the UK vaccine programme allows some NPI relaxation compared with a case with no vaccination. The outcome is that the vaccine programme in the UK has the potential to reduce the imposition of NPIs on March 7th by about 15%, without costing lives, this being the next time we in the UK are due for a major NPI review, potentially involving the return of schools at around March 7th.
The end of the beginning*
Now that it seems clear that a vaccination programme in the UK might start as early as next week, I have re-run my Covid-19 vaccination model for the UK, updating the November 25th scenarios (which begin on January 1st 2021) to reflect some potential UK outcomes.
Modelling of vaccine strategies
In my most recent post on November 18th, about updating my Coronavirus model to handle the impact of vaccines, I gave some examples of how case numbers, and more specifically death rates might be improved for the UK through a vaccination programme. Now that there seem to be several vaccines imminent, with efficacies ranging from 70% (Astra-Zeneca/Oxford) through 90% (A-Z/O via a different inoculation regime, and Pfizer), to 95% (Moderna) and several others in the mix, I explore some sensitivities in more detail, and also apply the model to the USA.
Vaccine, vaccine, vaccine, vaciiiine,…(don’t refuse it, just because you can)
In the news today, I read that Dolly Parton had given $1,000,000, through her Covid-19 Research Fund, to help fund the Moderna vaccine development. As The Times newspaper reported, this – erm – somewhat trumps the White House contribution to public safety. In her honour, Ryan Cordell composed and performed this ditty. The timing neatly coincides with the work I have been doing to incorporate vaccination into my Coronavirus model, and to that end I have been researching ways of modelling vaccination. I have made some appropriate changes, and run some model options for different vaccine efficacy; vaccinations per day; and date of starting the vaccination programme.